---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041494"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:45:22.557747+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Better Choice expects combined 2025 revenue ~$270M, EBITDA ~$10M; SRx Health acquisition close imminent

## Summary
- Combined 2025 pro forma revenue over $270M and EBITDA over $10M, based on management assumptions.
- Transaction expected to close late Q4 2024 or early Q1 2025; all-stock deal valued at ~$125M.
- Combined TTM revenue $235M (+25% QoQ); expected annual cost savings ~$1.7M.
- Better Choice Q2 2024 adjusted EBITDA near break-even (-$0.03M); SRx Health had CAD$180M revenue in 2023.
- Pro forma fully diluted shares 22.9M; insiders own ~75%; net tangible book value $4.07/share.

## SEC filing metadata
- accession: 0001493152-24-041494
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315224041494/0001493152-24-041494-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315224041494/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041494
- JSON: https://secwatch.observer/filing/0001493152-24-041494.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041494.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.